| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 750493 | 2-(2-hydroxyphenyl)-3-[5-(1H-imidazol-1-ylmethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazolidin-4-one | 0.0260391472224207 | 0.03471594 |
| NSC 761130 | (E)-6-chloro-3-((2-(4-fluorophenyl)imidazo[1,2-a]pyridin-3-yl)methylene)indolin-2-one | 0.0260391472224207 | 0.23486585 |
| NSC 107043 | Null | 0.0267520285931239 | 0.24054825 |
| NSC 113423 | NSC 113423 | 0.0267520285931239 | 0.33435431 |
| NSC 132277 | Ethanesulfonic acid, compd. with 1,6-dihydro-6,6-dimethyl-1-[4-(4-phenylbutyl)phenyl]-1,3,5-triazine-2,4-diamine (1:1) | 0.0267520285931239 | 0.33850668 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0267520285931239 | 0.34488792 |
| NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.0267520285931239 | -0.17709613 |
| NSC 15795 | Null | 0.0267520285931239 | 0.11865343 |
| NSC 339705 | 5H-Indeno[1,2-c]isoquinoline-5,11(6H)-dione, 6-(2-hydroxyethyl)- | 0.0267520285931239 | 0.17397094 |
| NSC 372939 | Null | 0.0267520285931239 | 0.35493123 |